Related Experiment Videos
Monoclonal antibodies recognize antigen expressed by osteoblasts
D Benayahu1, M Efrati, S Wientroub
1Department of Cell Biology and Histology, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Summary
Researchers developed novel monoclonal antibodies (MoAbs) targeting mouse marrow stroma (MMS) antigens. One MoAb, MMS-85/12, specifically identifies an osteoblast-associated antigen, aiding in bone cell research.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Monoclonal antibodies (MoAbs) are crucial tools for identifying specific cellular antigens.
- Mouse marrow stroma (MMS) contains various cell types, including osteoblasts and adipocytes, with distinct roles in bone homeostasis.
Purpose of the Study:
- To generate and characterize MoAbs against MMS antigens.
- To identify MoAbs that specifically recognize osteoblastic cells within the bone marrow stroma.
Main Methods:
- Generation of MoAbs using the MBA-15 osteogenic cell line.
- Screening of MoAbs against diverse cell and tissue types.
- Immunohistochemistry, Western blotting, and immunoprecipitation to characterize antigen-antibody interactions.
Main Results:
- A series of MoAbs against MMS antigens were developed (MMS-25/17, MMS-85/12, MMS-302/40, MMS-319/4).
- MMS-85/12 demonstrated high specificity for osteoblastic cells and primary bone marrow cultures (BMC), distinguishing them from marrow adipocytes.
- The target antigen recognized by MMS-85/12 is located on the plasma membrane and in the extracellular matrix of osteoblasts and has a molecular weight of 84 kDa.
Conclusions:
- MMS-85/12 is a valuable MoAb for identifying osteoblastic cells.
- This MoAb can be used to study osteoblast function and bone marrow stroma composition.
- The identified antigen may play a role in osteoblast differentiation or function.